Document is current
Any future updates will be listed below
-
Authors
Koh, Seong-Ho http://orcid.org/0000-0001-5419-5761
Kwon, Hyuk Sung
Choi, Seong Hye
Jeong, Jee Hyang
Na, Hae Ri
Lee, Chan Nyoung
Yang, YoungSoon
Lee, Ae Young
Lee, Jae-Hong
Park, Kyung Won
Han, Hyun Jeong
Kim, Byeong C.
Park, Jin Se
Lee, Jee-Young
Kim, Sangjae
Lee, Kyu-Yong
-
Funding
Funding for this research was provided by:
Ministry of Science, ICT and Future Planning (2018R1A2A2A15023219)
Ministry of Health and Welfare (HI20C0253)
Medical Research Center (2017R1A5A2015395)
GemVax and KAEL
- License Information
-
More Information
Article History
Received: 16 November 2020
Accepted: 8 March 2021
First Online: 26 March 2021
Declarations
:
: The study protocol was approved by the independent institutional review boards of each participating center. The process was performed according to Good Clinical Practice guidelines. All participants provided written informed consent.
: Not applicable
: KSJ is an employer of GemVax & Kael Co., Ltd. and holds equity in the company. Other authors declare no competing interests.
